Chang‐Qing Zhu - Concepedia

Author

Chang‐Qing Zhu

Research Triangle Park Foundation ORCID

Also Known As

C Zhu, C.-.Q. Zhu, C.-Q. Zhu, C.Q. Zhu, Chang-Qing Zhu, Chang-qing Zhu, Changqing Zhu, Chang‐Qing Zhu

Publications

942

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation University of Pennsylvania GlaxoSmithKline (United States)GlaxoSmithKline (United Kingdom)University College London

About

Chang‐Qing Zhu is an author at Research Triangle Park Foundation specializing in cardiovascular disease, medicine, and pulmonary disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	154
2	Public Health	1	1	12
3	Epidemiology	1	1	12
4	Newborn Medicine	1	1	142
5	Pulmonary Disease	1	1	12

Chang‐Qing Zhu

Publications

872

Citations

H-Index

Page 1

	Year	Citations
FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease David A. Lipson, Helen Barnacle, Ruby Birk, American Journal of Respiratory and Critical Care Medicine	2017	323
Intra-arterial blood pressure reference ranges, death and morbidity in very low birthweight infants during the first seven days of life Steve Cunningham, Andrew Symon, Robert A. Elton, Early Human Development HypertensionNeonatologyCardiovascular DiseaseInfant NutritionPediatrics	1999	142
Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial Dave Singh, Sally Worsley, Chang‐Qing Zhu, BMC Pulmonary Medicine	2015	62
Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study Peter Bremner, Ruby Birk, Noushin Brealey, Respiratory Research	2018	57
Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD Sandeep Bansal, Martin Anderson, Antonio Anzueto, npj Primary Care Respiratory Medicine	2021	40
Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials Gary T. Ferguson, Nicola J. Brown, Chris Compton, Respiratory Research	2020	39
Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study Edward Kerwin, Chris Kalberg, Dmitry Galkin, International Journal of COPD	2017	34
Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life Maggie Tabberer, David A. Lomas, Ruby Birk, Advances in Therapy	2018	30
Preventing clinically important deterioration with single-inhaler triple therapy in COPD Ian Naya, Chris Compton, Afisi Ismaila, ERJ Open Research	2018	25
Peak Inspiratory Flow Rate in COPD: An Analysis of Clinical Trial and Real-World Data Martin Anderson, Kathryn Collison, Michael Drummond, International Journal of COPD	2021	24

Page 1